Dr. Lilit Antonyan
Research Scientist
Dr. Lilit Antonyan is a research scientist based in Montreal, Canada, with
deep expertise in rare genetic disorders. Her work focuses on the generation
of stem cell (iPSC) models, the investigation of molecular mechanisms
that drive disease, and the development of targeted therapies.
She earned her PhD in Genetics from McGill University, where she led pioneering research into Schinzel-Giedion Syndrome and SETBP1 haploinsufficiency disorder. Her doctoral work was instrumental in characterizing these conditions as protein dosage disorders in iPSC-derived neural cells. Most notably, Dr. Antonyan was the first to propose and develop an RNA based therapeutic approach for SGS using antisense oligonucleotides — offering a promising path forward in the search for effective treatments for SGS. Her scientific expertise and innovative contributions to the field make her a valuable member of our advisory board.
She earned her PhD in Genetics from McGill University, where she led pioneering research into Schinzel-Giedion Syndrome and SETBP1 haploinsufficiency disorder. Her doctoral work was instrumental in characterizing these conditions as protein dosage disorders in iPSC-derived neural cells. Most notably, Dr. Antonyan was the first to propose and develop an RNA based therapeutic approach for SGS using antisense oligonucleotides — offering a promising path forward in the search for effective treatments for SGS. Her scientific expertise and innovative contributions to the field make her a valuable member of our advisory board.
